X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (726) 726
Publication (44) 44
Conference Proceeding (14) 14
Book Review (13) 13
Book Chapter (4) 4
Patent (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (309) 309
index medicus (268) 268
multiple sclerosis (253) 253
clinical neurology (210) 210
neurosciences (181) 181
female (135) 135
animals (120) 120
male (119) 119
immunology (103) 103
adult (102) 102
neurology (92) 92
multiple-sclerosis (90) 90
middle aged (88) 88
mice (75) 75
inflammation (68) 68
natalizumab (65) 65
central-nervous-system (63) 63
t cells (63) 63
experimental autoimmune encephalomyelitis (61) 61
multiple sclerosis - immunology (60) 60
aged (54) 54
analysis (54) 54
lymphocytes (53) 53
multiple sclerosis - drug therapy (52) 52
psychiatry (51) 51
research (48) 48
disease (46) 46
abridged index medicus (42) 42
t-cells (42) 42
medicine & public health (41) 41
progressive multifocal leukoencephalopathy (41) 41
immunotherapy (40) 40
magnetic resonance imaging (40) 40
mice, inbred c57bl (40) 40
cells, cultured (39) 39
treatment outcome (39) 39
autoimmunity (38) 38
dendritic cells (38) 38
expression (38) 38
flow cytometry (36) 36
therapy (36) 36
care and treatment (35) 35
activation (34) 34
double-blind (33) 33
risk factors (33) 33
cell biology (32) 32
central nervous system (32) 32
diagnosis (32) 32
placebo-controlled trial (32) 32
t-lymphocytes - immunology (32) 32
brain (31) 31
health aspects (31) 31
encephalomyelitis, autoimmune, experimental - immunology (30) 30
multidisciplinary sciences (30) 30
lymphocytes t (29) 29
medicine (29) 29
young adult (29) 29
disease models, animal (28) 28
multiple sclerosis - pathology (28) 28
adolescent (27) 27
disease progression (27) 27
mice, knockout (27) 27
multiple sclerosis, relapsing-remitting - drug therapy (26) 26
article (25) 25
pathology (25) 25
time factors (25) 25
immunologic factors - therapeutic use (24) 24
patients (24) 24
antibodies (23) 23
cytokines (23) 23
immunomodulation (23) 23
monoclonal antibodies (23) 23
nervous system (23) 23
pathogenesis (23) 23
drug therapy (22) 22
experimental allergic encephalomyelitis (22) 22
glatiramer acetate (22) 22
physiological aspects (22) 22
research article (22) 22
alemtuzumab (21) 21
brain - pathology (21) 21
encephalomyelitis (21) 21
multiple sclerosis - therapy (21) 21
neurology. diseases of the nervous system (21) 21
t-lymphocytes, regulatory - immunology (21) 21
biochemistry & molecular biology (20) 20
biology (20) 20
central nervous system - immunology (20) 20
cerebrospinal-fluid (20) 20
encephalomyelitis, autoimmune, experimental - pathology (20) 20
fingolimod (20) 20
immune system (20) 20
immunohistochemistry (20) 20
immunosuppressive agents - therapeutic use (20) 20
lymphocyte activation - immunology (20) 20
pharmacology & pharmacy (20) 20
antibodies, monoclonal - therapeutic use (19) 19
apoptosis (19) 19
blood (19) 19
interferon-beta (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF EXPERIMENTAL MEDICINE, ISSN 0022-1007, 08/2014, Volume 211, Issue 9, pp. 1833 - 1846
The focus of this study is the characterization of human T cell blood-brain barrier migration and corresponding molecular trafficking signatures. We examined... 
MEDICINE, RESEARCH & EXPERIMENTAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | IMMUNE CELLS | MULTIPLE-SCLEROSIS | NATALIZUMAB TREATMENT | INTEGRIN | P-SELECTIN | CENTRAL-NERVOUS-SYSTEM | PLACEBO-CONTROLLED TRIAL | IMMUNOLOGY | BLOOD-BRAIN-BARRIER | LYMPHOCYTES
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article